North America Biosurgery Market – Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Sep 2019
  • North America
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

North America Biosurgery Market By Product (Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants & Adhesives, Adhesion Barriers, Staple-Line Reinforcement Agents), Application (General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurological Surgery, Reconstructive Surgery, Gynecological Surgery, Thoracic Surgery, Urological Surgery), Country (U.S., Canada and Mexico) – Industry Trends and Forecast to 2026

Market Analysis: North America Biosurgery Market

North America biosurgery market is registering a substantial CAGR of 8.21% in the forecast period of 2019-2026. The rise in the market can be attributed due to the surge in the elderly population which is contributing of the growth of the market.

Market Definition: North America Biosurgery Market

The surge in the elderly population is raising the rate of surgeries being performed. Biosurgery has become the most preferred surgery as it has less intra and post complications. It is a type of surgical method that involves the usage of various natural and synthetically produced surgical products. These products are used to isolate the wound and prevent the blood loss by soaking the fluids and sealing the wound. Implementation of these products helps in complications associated with surgeries and helps in reducing the time required post-treatment.

Market Drivers

  • Rising elderly population is driving the market growth
  • Increasing demand for innovative product developments and launches for the management of blood loss in patients undergoing surgical procedures is boosting the market growth
  • Surging  trauma-related wounds is fueling the market growth
  • The various advantages of biosurgeires over the traditional methods is expanding the market growth
  • The surge in the joint reconstruction and spinal fusion is driving the market growth

Market Restraints

  • The rise in the cost of the surgical procedures is hindering the market growth
  • Stringent Regulatory Approval is hampering the market growth
  • Due to lack of awareness and societal disapproval the growth of the market is shrinking
  • The surging acceptance of minimally invasive surgeons is hampering the market growth

Segmentation: North America Biosurgery Market

By Product

  • Bone-Graft Substitutes

    • Demineralized Bone Matrix
    • Synthetic Bone Grafts
    • Bone Morphogenetic Proteins
    • Others

  • Soft-Tissue Attachments

    • Synthetic Meshes
    • Biological Meshes

      • Allografts
      • Xenografts

  • Hemostatic Agents

    • Thrombin-Based Hemostatic Agents
    • Oxidized Regenerated Cellulose-Based Hemostatic Agents
    • Combination Hemostatic Agents

  • Surgical Sealants & Adhesives

    • Natural/Biological Sealants & Adhesives

      • Fibrin Sealants
      • Collagen-Based Sealants
      • Gelatin-Based Sealants
      • Albumin-Based Sealants
      • Others

    • Natural/Biological Sealants & Adhesives

      • Human Blood-Based Sealants & Adhesives
      • Animal-Based Sealants & Adhesives

    • Synthetic & Semi-Synthetic Sealants & Adhesives

      • Peg Hydrogels
      • Cyanoacrylate-Based Sealants & Adhesives
      • Urethane-Based Sealants & Adhesives
      • Others

  • Adhesion Barriers

    • Synthetic Adhesion Barriers

      • Hyaluronic Acid-Based Adhesion Barriers
      • Regenerated Cellulose-Based Adhesion Barriers
      • Peg-Based Adhesion Barriers
      • Ther Synthetic Adhesion Barriers

    • Natural Adhesion Barriers

      • Collagen & Protein Adhesion Barriers
      • Fibrin-Based Adhesion Barriers

  • Staple-Line Reinforcement Agents

By Application

  • General Surgery
  • Cardiovascular Surgery
  • Orthopedic Surgery
  • Neurological Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Thoracic Surgery
  • Urological Surgery

By Country

  • U.S.
  • Canada
  • Mexico

Key Developments in the Market:

  • In May 2018, Aroa Biosurgery had partnered with Hydrofera to launch Appulse in North America. The product will ensure the level of safety for the patients. Hydrofera has product division of two natural organic pigments and antibacterial wound dressings. The grouping of two technological platforms will enable line of advanced wound dressings that lowers the treatment cost and improve patient outcomes.
  • In November 2016, Johnson & Johnson Services Inc. had launched Evarrest Fibrin Sealant Patch. It is used by surgeons to stop bleeding at the time of surgery. It can stop the bleeding in the single attempt as well as it is very effective and safe to use. The launch will enable the surgeons to conduct their surgery successfully.

Competitive Analysis:

North America biosurgery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of biosurgery market for U.S., Canada and Mexico.

Key Market Competitors:

Few of the major market competitors currently working in the North America biosurgery market are Medtronic, Stryker, Johnson & Johnson Services Inc., Baxter, BD, Aroa Biosurgery Limited, CryoLife Inc., Sanofi, CSL Limited, Integra LifeSciences Corporation, Pfizer Inc., B. Braun Melsungen AG, Cardinal Health, Tissue Regenix and Getinge AB among others.

Research Methodology:  North America Biosurgery Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of North America biosurgery market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19